abhishreshthaa
Abhijeet S
American Home Mortgage Investment Corporation (Pink Sheets: AHMIQ) was the 10th largest retail mortgage lender in the United States and was structured as a real estate investment trust (REIT).
It has filed for bankruptcy.[1]. The company stated that it was focused on earning net interest income from self-originated loans and mortgage-backed securities, and through its taxable subsidiaries, from originating and servicing mortgage loans for institutional investors.
Mortgages were originated through the company's employees as well as through mortgage brokers and purchased from correspondent lenders and were serviced at the company's servicing center in Irving, Texas.
The company filed for Chapter 11 bankruptcy protection in Wilmington Delaware federal court, on August 6, 2007. The week before the filing, the company said that many of its lenders had demanded their money back, and that AHM was also unable to deliver on about US$ 800 million in commitments for housing loans, and had laid off nearly ninety percent of its 7,000 employees.
Strengths
* Global presence
* Impressive growth forecast for Humira across a wide range of autoimmune disorders
* Robust lipid management portfolio supported by a range of pipeline programs
* Strong record of lifecycle management crucial in view of forthcoming patent expires
* Innovation leader in the industry
Weaknesses
* Upcoming patent expires
* Narrow phase III pipeline, with little in the way of explosive launch opportunities
* Late-stage pipeline currently offers limited expansion beyond existing therapeutic positions
Opportunities
* License agreements
* Launch of Flutiform
* Positive outlook for diagnostics market
Threats
* Unprecedented generic erosion exacerbated by ineffective product lifecycle launches
* Government regulation
* Industry consolidation
It has filed for bankruptcy.[1]. The company stated that it was focused on earning net interest income from self-originated loans and mortgage-backed securities, and through its taxable subsidiaries, from originating and servicing mortgage loans for institutional investors.
Mortgages were originated through the company's employees as well as through mortgage brokers and purchased from correspondent lenders and were serviced at the company's servicing center in Irving, Texas.
The company filed for Chapter 11 bankruptcy protection in Wilmington Delaware federal court, on August 6, 2007. The week before the filing, the company said that many of its lenders had demanded their money back, and that AHM was also unable to deliver on about US$ 800 million in commitments for housing loans, and had laid off nearly ninety percent of its 7,000 employees.
Strengths
* Global presence
* Impressive growth forecast for Humira across a wide range of autoimmune disorders
* Robust lipid management portfolio supported by a range of pipeline programs
* Strong record of lifecycle management crucial in view of forthcoming patent expires
* Innovation leader in the industry
Weaknesses
* Upcoming patent expires
* Narrow phase III pipeline, with little in the way of explosive launch opportunities
* Late-stage pipeline currently offers limited expansion beyond existing therapeutic positions
Opportunities
* License agreements
* Launch of Flutiform
* Positive outlook for diagnostics market
Threats
* Unprecedented generic erosion exacerbated by ineffective product lifecycle launches
* Government regulation
* Industry consolidation